DarioHealth Corp. (DRIO) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
38/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseDRIO / S&P -17.71% / 15.20% |
LoseDRIO / S&P -22.65% / 15.00% |
LoseDRIO / S&P -53.60% / 50.40% |
| 2026-Q10/3 |
LoseDRIO / S&P -29.53% / -4.33% |
LoseDRIO / S&P -24.41% / 11.30% |
LoseDRIO / S&P -9.54% / 27.70% |
| 2025-Q41/3 |
LoseDRIO / S&P -34.41% / 2.65% |
LoseDRIO / S&P -17.31% / 9.00% |
WinDRIO / S&P 47.46% / 13.40% |
| 2025-Q33/3 |
WinDRIO / S&P 29.48% / 8.12% |
WinDRIO / S&P 7.29% / 4.61% |
WinDRIO / S&P 101.07% / 13.45% |
| 2025-Q22/3 |
LoseDRIO / S&P 9.48% / 10.94% |
WinDRIO / S&P 41.79% / 4.83% |
WinDRIO / S&P 1019.49% / 10.63% |
| 2025-Q12/3 |
LoseDRIO / S&P -22.14% / -4.27% |
WinDRIO / S&P 47.21% / 4.98% |
WinDRIO / S&P 480.36% / 10.57% |
| 2024-Q42/3 |
LoseDRIO / S&P -29.82% / 2.41% |
WinDRIO / S&P 32.86% / 5.25% |
WinDRIO / S&P 266.84% / 6.15% |
| 2024-Q31/3 |
LoseDRIO / S&P -5.88% / 5.89% |
LoseDRIO / S&P -2.09% / 5.89% |
WinDRIO / S&P 174.51% / 6.11% |
| 2024-Q20/3 |
LoseDRIO / S&P -22.22% / 4.28% |
LoseDRIO / S&P -28.11% / 5.38% |
LoseDRIO / S&P -46.12% / 5.12% |
| 2024-Q10/3 |
LoseDRIO / S&P -11.05% / 10.56% |
LoseDRIO / S&P -28.58% / 5.71% |
LoseDRIO / S&P -28.51% / 5.59% |
| 2023-Q40/3 |
LoseDRIO / S&P -47.56% / 11.69% |
LoseDRIO / S&P -26.41% / 6.81% |
LoseDRIO / S&P -26.89% / 7.78% |
| 2023-Q30/3 |
LoseDRIO / S&P -18.20% / -3.27% |
LoseDRIO / S&P -12.39% / 7.52% |
LoseDRIO / S&P -36.45% / -5.03% |
| 2023-Q20/3 |
LoseDRIO / S&P -2.67% / 8.74% |
LoseDRIO / S&P 2.83% / 9.50% |
LoseDRIO / S&P -41.60% / -8.57% |
| 2023-Q10/3 |
LoseDRIO / S&P -3.74% / 7.50% |
LoseDRIO / S&P 6.75% / 10.77% |
LoseDRIO / S&P -41.25% / -15.69% |
| 2022-Q41/3 |
LoseDRIO / S&P -7.56% / 7.56% |
WinDRIO / S&P 34.82% / 11.88% |
LoseDRIO / S&P -36.84% / -17.99% |
| 2022-Q31/3 |
LoseDRIO / S&P -24.59% / -4.88% |
WinDRIO / S&P 62.24% / 13.47% |
LoseDRIO / S&P -68.06% / -1.41% |
| 2022-Q22/3 |
WinDRIO / S&P 5.14% / -16.10% |
WinDRIO / S&P 99.56% / 13.71% |
LoseDRIO / S&P -54.04% / 11.04% |
| 2022-Q11/3 |
LoseDRIO / S&P -54.97% / -4.60% |
WinDRIO / S&P 162.81% / 15.97% |
LoseDRIO / S&P -38.37% / 42.23% |
| 2021-Q41/3 |
LoseDRIO / S&P -4.98% / 11.03% |
WinDRIO / S&P 170.76% / 15.00% |
LoseDRIO / S&P DRIO unavailable / 96.40% |
| 2021-Q31/3 |
LoseDRIO / S&P -36.10% / 0.58% |
WinDRIO / S&P 127.10% / 10.77% |
LoseDRIO / S&P DRIO unavailable / 69.42% |
| 2021-Q22/3 |
WinDRIO / S&P 10.90% / 8.55% |
WinDRIO / S&P 82.28% / 6.58% |
LoseDRIO / S&P DRIO unavailable / 51.81% |
| 2021-Q12/3 |
WinDRIO / S&P 34.78% / 6.17% |
WinDRIO / S&P 36.08% / -1.06% |
LoseDRIO / S&P DRIO unavailable / 7.39% |
| 2020-Q41/3 |
LoseDRIO / S&P -14.84% / 12.15% |
WinDRIO / S&P 0.22% / -3.72% |
LoseDRIO / S&P DRIO unavailable / -33.42% |
| 2020-Q31/3 |
WinDRIO / S&P 164.25% / 8.93% |
LoseDRIO / S&P -2.24% / -2.04% |
LoseDRIO / S&P DRIO unavailable / -27.10% |
| 2020-Q20/3 |
LoseDRIO / S&P -6.48% / 20.54% |
LoseDRIO / S&P -4.71% / -0.46% |
LoseDRIO / S&P DRIO unavailable / -27.11% |
| 2020-Q11/3 |
WinDRIO / S&P 3.51% / -19.60% |
LoseDRIO / S&P -11.37% / 3.47% |
LoseDRIO / S&P DRIO unavailable / -14.75% |
| 2019-Q41/3 |
WinDRIO / S&P 2057.89% / 9.07% |
LoseDRIO / S&P 2.23% / 5.36% |
LoseDRIO / S&P DRIO unavailable / 2.99% |
| 2019-Q30/3 |
LoseDRIO / S&P -34.62% / 1.70% |
LoseDRIO / S&P 2.60% / 5.02% |
LoseDRIO / S&P DRIO unavailable / 0.21% |
| 2019-Q21/3 |
LoseDRIO / S&P -36.91% / 4.30% |
WinDRIO / S&P 10.40% / 6.64% |
LoseDRIO / S&P DRIO unavailable / 8.65% |
| 2019-Q11/3 |
LoseDRIO / S&P -5.03% / 13.65% |
WinDRIO / S&P 33.13% / 8.12% |
LoseDRIO / S&P DRIO unavailable / 14.29% |
| 2018-Q41/3 |
LoseDRIO / S&P -20.00% / -13.52% |
WinDRIO / S&P 43.02% / 9.05% |
LoseDRIO / S&P DRIO unavailable / 18.23% |
| 2018-Q31/3 |
LoseDRIO / S&P -24.22% / 7.71% |
WinDRIO / S&P 64.15% / 10.21% |
LoseDRIO / S&P DRIO unavailable / 19.06% |
| 2018-Q21/3 |
LoseDRIO / S&P -16.88% / 3.43% |
WinDRIO / S&P 78.91% / 9.03% |
LoseDRIO / S&P DRIO unavailable / 14.46% |
| 2018-Q11/3 |
LoseDRIO / S&P -3.87% / -0.76% |
WinDRIO / S&P 82.57% / 7.68% |
LoseDRIO / S&P DRIO unavailable / 12.46% |
| 2017-Q41/3 |
LoseDRIO / S&P -12.93% / 6.64% |
WinDRIO / S&P 84.45% / 7.03% |
LoseDRIO / S&P DRIO unavailable / 13.82% |
| 2017-Q31/3 |
LoseDRIO / S&P -15.60% / 4.48% |
WinDRIO / S&P 94.90% / 5.68% |
LoseDRIO / S&P DRIO unavailable / 17.57% |
| 2017-Q21/3 |
LoseDRIO / S&P -27.57% / 3.09% |
WinDRIO / S&P 108.09% / 4.83% |
LoseDRIO / S&P DRIO unavailable / 17.74% |
| 2017-Q11/3 |
LoseDRIO / S&P -7.38% / 6.07% |
WinDRIO / S&P 144.86% / 3.67% |
LoseDRIO / S&P DRIO unavailable / 13.32% |
| 2016-Q41/3 |
LoseDRIO / S&P -8.45% / 3.82% |
WinDRIO / S&P 240.58% / 2.09% |
LoseDRIO / S&P DRIO unavailable / 7.05% |
| 2016-Q31/3 |
LoseDRIO / S&P -31.07% / 3.85% |
WinDRIO / S&P 301.59% / 0.20% |
LoseDRIO / S&P DRIO unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | DRIO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -28.81% | 20.78% |
| Annualized return | -28.81% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | DRIO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.47% | 83.14% |
| Annualized return | -52.07% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | DRIO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -91.21% | 319.30% |
| Annualized return | -21.58% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |